-
No.1 Korda charges into share of LPGA Mexico lead
-
Young fires 67 to seize commanding PGA lead at Doral
-
US appeals court temporarily halts mail delivery of abortion pill
-
Joy for Norris in Miami as McLaren end Mercedes run
-
Leclerc offers hope to Ferrari fans in Miami
-
US to withdraw about 5,000 troops from Germany
-
'No going back' for Colombia's workers as the right eyes return
-
Norris on sprint pole as McLaren shine again
-
Venezuelan protesters call government wage hike a joke
-
Leeds beat Burnley to virtually secure Premier League survival
-
Gridlock as pandemic treaty talks fail to finish
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Immersive art: museum-goers in bikinis dive into Cezanne
-
Gaza activists disperse after flotilla halted by Israel off Crete
-
US sanctions are 'collective punishment,' says Cuba during May 1 marches
-
Top seeds Sinner, Zverev reach Madrid Open final
-
Pope names former undocumented migrant as US bishop of West Virginia
-
Delhi end slump with team-record chase against Rajasthan
-
Trump says will raise US tariffs on EU cars to 25%
-
AI actors and writers not eligible for Oscars: Academy
-
Rebels take key military base in Mali's north
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
Leclerc on top for Ferrari ahead of Verstappen and Piastri
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
Trump says will raise US tariffs on EU cars, trucks to 25%
-
Godon raises game to take Romandie stage and revenge over leader Pogacar
-
Celtic's O'Neill expects no let-up from Hibs despite fans' feelings
-
Pope names former undocumented migrant as US bishop
-
Javelin star Kitaguchi teams up with Czech legend Zelezny
-
Sawe sub-2hr marathon captured 'global imagination' says Coe
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Sinner shines to beat Fils, reach Madrid Open final
-
UK court clears comedy writer of damaging transgender activist's phone
-
Was LIV Golf an expensive failure for Saudis? Not everyone thinks so
-
Coe hails IOC gender testing decision
-
McInnes wants Tynecastle in 'full glory' for Hearts title charge
-
McFarlane says troubled Chelsea still attractive to potential managers
-
Man Utd boss Carrick relishes 'special' Liverpool rivalry
-
Baguettes take centre stage on France's Labour Day
-
Spurs must banish 'loser' mentality despite injury woes, says De Zerbi
-
Arsenal must manage emotions of title race says Arteta
-
Nepal temple celebrates return of stolen Buddha statue
-
US Fed official says rate hikes may be needed if inflation surges
-
Fixture pile-up no excuse for Man City in title race: Guardiola
-
Iran offers new proposal amid stalled US peace talks
-
Gulf countries' plans to bypass Hormuz still far off, experts warn
-
Luis Enrique says 'unique' PSG-Bayern first leg could have gone either way
-
Rebels take key military camp in Mali's north
-
Activists on Gaza aid flotilla seized by Israeli forces disembark in Crete
-
Turkish police fire tear gas, arrest hundreds at Istanbul May Day rallies
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
P.Cavaco--PC